What analysts say:
- Buy, sell, or hold?: Analysts think investors should stand pat on UniFirst with five of six analysts rating it a hold. Analysts don't like UniFirst as much as competitor Healthcare Services Group overall. Three out of six analysts rate Healthcare Services Group a buy compared to one of six for UniFirst. That rating hasn't budged in three months as analysts have remained unchanged in their opinion of the stock.
- Revenue Forecasts: On average, analysts predict $278.1 million in revenue this quarter. That would represent a rise of 6.5% from the year-ago quarter.
- Wall St. Earnings Expectations: The average analyst is estimating earnings of 85 cents per share. Estimates range from 81 cents to 87 cents.
What our community says:
CAPS All Stars are solidly backing the stock with 96.4% giving it an "outperform" rating. The community at large concurs with the All Stars with 89.7% granting it a rating of "outperform." Fools are keen on UniFirst, though the message boards have been quiet lately with only 26 posts in the past 30 days. The bullish CAPS rating of five out of five stars for UniFirst outpaces community enthusiasm for the company.
UniFirst's income has fallen year over year by an average of 2.1%. Revenue has now gone up for three straight quarters.
For all our UniFirst-specific analysis, including earnings and beyond, add UniFirst to My Watchlist.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.